P-271 Feasibility of neoadjuvant chemotherapy with modified FOLFOX6 (combination chemotherapy of infusional 5-FU/l-Leucovorin and intermittent oxaliplatin) with bevacizumab in patients with locally advanced lower rectal cancer

Lignende værker

• Oxaliplatin/5-FU without Leucovorin Chemotherapy in Metastatic Colorectal Cancer
  af: Shim, Byoung Yong, et al.
  Udgivet: (2005)
• Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer
  af: Messersmith, Wells A., et al.
  Udgivet: (2010)
• Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer
  af: Lorenzen, S, et al.
  Udgivet: (2013)
• Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4)
  af: Chen, Chin-Fan, et al.
  Udgivet: (2008)
• Oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX-4) Combination Chemotherapy as a Salvage Treatment in Advanced Gastric Cancer
  af: Kim, Young Saing, et al.
  Udgivet: (2010)